Skip to the page

Data / Form D filings / ImmuVen, Inc.

ImmuVen, Inc.: Form D filings

ImmuVen, Inc., a biotechnology company in Champaign, IL, filed 3 Form D notices with the SEC between 2009 and 2011. The latest, on August 15, 2011, reports $250,000 sold of an offering with no set size to 5 investors.

Find out what ImmuVen, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
60 HAZELWOOD DRIVE, Champaign, IL, 61820
Phone
(858) 768-1720
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Illinois
Year incorporated
2007
Revenue range
$1 - $1,000,000
Exemptions claimed
Rule 504
SEC identifier (CIK)
1468696

The full lists. Form D filings in Illinois: 1,511 rows, $75.55, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 15, 2011New noticeIndefinite$250,000Indefinite5Jun 22, 2009sec.gov
Sep 13, 2010AmendmentIndefinite$255,000Indefinite4Jun 22, 2009sec.gov
Jul 22, 2009New notice$205,000$205,000$03Jun 22, 2009sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
David M KranzExecutive Officer, Director, Promoter
Patrick M SchlievertExecutive Officer, Director, Promoter
Cheryl Lee QuinnExecutive Officer
Cheryl Lee QuinnExecutive Officer

Other biotechnology companies in Illinois that filed recently

Every Form D from the week of Aug 15, 2011 · All recent filings in Illinois · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what ImmuVen, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.